Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.935 USD | +1.84% | +1.58% | -2.53% |
Mar. 08 | Truist Securities Adjusts Price Target on Compugen to $5 From $4, Maintains Buy Rating | MT |
Mar. 05 | Transcript : Compugen Ltd., Q4 2023 Earnings Call, Mar 05, 2024 |
Financials (USD)
Sales 2024 * | 37.9M | Sales 2025 * | 35.29M | Capitalization | 170M |
---|---|---|---|---|---|
Net income 2024 * | -13M | Net income 2025 * | -29M | EV / Sales 2024 * | 4.49 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 4.82 x |
P/E ratio 2024 * |
-14.6
x | P/E ratio 2025 * |
-7.04
x | Employees | 68 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.62% |
Latest transcript on Compugen Ltd.
1 day | -0.52% | ||
1 week | +1.06% | ||
Current month | -26.36% | ||
1 month | -24.90% | ||
3 months | -9.95% | ||
6 months | +160.63% | ||
Current year | -4.04% |
Managers | Title | Age | Since |
---|---|---|---|
Anat Cohen-Dayag
CEO | Chief Executive Officer | 57 | 01-12-31 |
Alberto Sessa
DFI | Director of Finance/CFO | 61 | 22-10-31 |
Eran Ophir
CTO | Chief Tech/Sci/R&D Officer | - | 14-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Paul Sekhri
CHM | Chairman | 66 | 17-10-01 |
Sanford Zweifach
BRD | Director/Board Member | 68 | 18-06-10 |
Gilead Halevy
BRD | Director/Board Member | 57 | 18-06-10 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 1.93 | +1.58% | 287 447 |
24-04-25 | 1.9 | -0.52% | 268,596 |
24-04-24 | 1.91 | -3.54% | 164,671 |
24-04-23 | 1.98 | +4.76% | 237,668 |
24-04-22 | 1.89 | -0.53% | 202,009 |
Delayed Quote Nasdaq, April 25, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.04% | 170M | |
+1.12% | 42.59B | |
+6.77% | 40.65B | |
+47.53% | 40.57B | |
-11.96% | 26.77B | |
+6.01% | 24.81B | |
-24.92% | 18.17B | |
-3.63% | 11.7B | |
+27.16% | 12.05B | |
+7.30% | 11.1B |
- Stock Market
- Equities
- CGEN Stock